PremiumCompany AnnouncementsArtrya Limited Announces Leadership Transition Ahead of U.S. Market Launch Artrya Limited Announces Quotation of New Securities on ASX Artrya Limited Issues Shares Following Employee Incentive Exercise PremiumCompany AnnouncementsArtrya Limited Announces Cessation of Securities Artrya Limited Secures FDA Clearance and Expands Market Reach Artrya Limited Issues Unlisted Options to Bolster Financial Strategy PremiumCompany AnnouncementsArtrya Limited Issues Shares on Performance Rights Conversion Artrya Secures Major Contract with Lumus Imaging for AI-Driven Heart Disease Diagnosis Artrya Limited Secures FDA Clearance for Salix® Coronary Anatomy